Centessa Pharmaceuticals plc. (CNTA) NASDAQ

$11.29 0.19 (1.71%)

Market Cap: $1.08B

As of 03/28/24 03:59 PM EDT. Market closed.

(CNTA)

Centessa Pharmaceuticals plc. (CNTA)
NASDAQ

$11.29
0.19 (1.71%)

Market Cap: $1.08B

As of 03/28/24 03:59 PM EDT. Market closed.

Add to Portfolio

centessa pharmaceuticals plc is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. the company applies an asset-centric r&d model at scale to advance a portfolio of highly validated programs led by industry leading teams. each program is developed by a centessa subsidiary and supported by a centralized infrastructure and the centessa ... read more

centessa pharmaceuticals plc is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. the company applies an asset-centric r&d model at scale to advance a portfolio of highly validated programs led by industry leading teams. each program is developed by a centessa subsidiary and supported by a centralized infrastructure and the centessa management team. the company is headquartered in cambridge, mass. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
12
Address
.
PRICE CHART FOR CENTESSA PHARMACEUTICALS PLC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$10.99
Previous Close
$11.10
Days Range
$10.53 - $11.21
52 week range
$3.52 - $12.45
Volume
172,356
Avg. Volume (30 days)
195,945
Market Cap
$1.08B
Dividend Yield
-
P/E
-
Shares Outstanding
97,629,345
Open
$10.99
Previous Close
$11.10
Days Range
$10.53 - $11.21
52 week range
$3.52 - $12.45
Volume
172,356
Avg. Volume (30 days)
195,945
Market Cap
$1.08B
Dividend Yield
-
P/E
-
Shares Outstanding
97,629,345
FINANCIAL STATEMENTS FOR CENTESSA PHARMACEUTICALS PLC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CENTESSA PHARMACEUTICALS PLC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Anderson Karen M.Chief People OfficerMar 25, 2024 Option Exercise$3.9445,000177,252122,685Mar 26, 2024, 04:16 PM
Anderson Karen M.Chief People OfficerMar 25, 2024 Sale$11.8851,160607,96092,690Mar 26, 2024, 04:16 PM
CHAO DAVID MChief Administrative OfficerFeb 01, 2024 Option Exercise$8.199,50377,830283,371Feb 02, 2024, 05:10 PM
HUSSAIN IQBAL JGeneral CounselFeb 01, 2024 Option Exercise$8.197,88564,578220,050Feb 02, 2024, 05:09 PM
Weinhoff Gregory MChief Financial OfficerFeb 01, 2024 Option Exercise$8.1911,49494,136276,853Feb 02, 2024, 05:08 PM
SAHA SAURABHChief Executive OfficerFeb 01, 2024 Option Exercise$8.1926,323215,585904,450Feb 02, 2024, 05:07 PM
Bush Tia LChief Quality OfficerFeb 01, 2024 Option Exercise$8.193,86231,630176,483Feb 02, 2024, 05:04 PM
Rotman HarrisSVP Regulatory AffairsFeb 01, 2024 Option Exercise$8.194,10833,64566,892Feb 02, 2024, 05:03 PM
Rotman HarrisSVP Regulatory AffairsFeb 01, 2024 Sale$8.104,26734,57462,625Feb 02, 2024, 05:03 PM
Anderson Karen M.Chief People OfficerFeb 01, 2024 Option Exercise$8.197,26559,50077,685Feb 02, 2024, 05:02 PM
CHAO DAVID MChief Administrative OfficerDec 31, 2023 Option Exercise$7.9610,41982,935255,374Jan 02, 2024, 07:46 PM
Weinhoff Gregory MChief Financial OfficerDec 31, 2023 Option Exercise$7.9611,74293,466257,097Jan 02, 2024, 07:45 PM
HUSSAIN IQBAL JGeneral CounselDec 31, 2023 Option Exercise$7.967,52059,859185,435Jan 02, 2024, 07:44 PM
SAHA SAURABHChief Executive OfficerDec 31, 2023 Option Exercise$7.9636,263288,653786,573Jan 02, 2024, 07:43 PM
GRAINGER DAVID JChief Innovation OfficerDec 31, 2023 Option Exercise$7.964,70037,412962,790Jan 02, 2024, 07:41 PM
Bush Tia LChief Quality OfficerDec 31, 2023 Option Exercise$7.966,41951,095137,845Jan 02, 2024, 07:37 PM
HUSSAIN IQBAL JGeneral CounselSep 30, 2023 Option Exercise$6.477,52048,654192,955Oct 03, 2023, 05:00 PM
GRAINGER DAVID JChief Innovation OfficerSep 30, 2023 Option Exercise$6.474,70030,409967,490Oct 03, 2023, 04:59 PM
Weinhoff Gregory MChief Financial OfficerSep 30, 2023 Option Exercise$6.4711,74275,971268,839Oct 03, 2023, 04:56 PM
SAHA SAURABHChief Executive OfficerSep 30, 2023 Option Exercise$6.4736,263234,622822,836Oct 03, 2023, 04:53 PM
CHAO DAVID MChief Administrative OfficerSep 30, 2023 Option Exercise$6.4710,41967,411265,793Oct 03, 2023, 04:51 PM
Bush Tia LChief Quality OfficerSep 30, 2023 Option Exercise$6.476,41941,531144,264Oct 03, 2023, 04:46 PM
Rotman HarrisSVP Regulatory AffairsSep 20, 2023 Option Exercise$4.3737,484163,68870,984Sep 22, 2023, 04:47 PM
Rotman HarrisSVP Regulatory AffairsSep 20, 2023 Sale$6.2937,484235,68833,500Sep 22, 2023, 04:47 PM
CHAO DAVID MChief Administrative OfficerJun 30, 2023 Option Exercise$5.9010,41961,473276,212Jul 03, 2023, 05:35 PM
HUSSAIN IQBAL JGeneral CounselJun 30, 2023 Option Exercise$5.907,10441,914200,475Jul 03, 2023, 05:34 PM
Weinhoff Gregory MChief Financial OfficerJun 30, 2023 Option Exercise$5.9011,74269,279280,581Jul 03, 2023, 05:33 PM
SAHA SAURABHChief Executive OfficerJun 30, 2023 Option Exercise$5.9036,263213,955859,099Jul 03, 2023, 05:32 PM
GRAINGER DAVID JChief Innovation OfficerJun 30, 2023 Option Exercise$5.904,29025,311972,190Jul 03, 2023, 05:31 PM
Bush Tia LChief Quality OfficerJun 30, 2023 Option Exercise$5.906,41937,873150,683Jul 03, 2023, 05:29 PM
YVER ANTOINEEVP & Chairman of DevelopmentJun 01, 2023 Sale$4.456,50028,949783,066Jun 02, 2023, 05:01 PM
Bush Tia LChief Quality OfficerMay 24, 2023 Sale$4.488,00035,8653,000May 26, 2023, 05:01 PM
YVER ANTOINEEVP & Chairman of DevelopmentMay 01, 2023 Sale$4.426,80030,083789,566May 02, 2023, 05:01 PM
Weinhoff Gregory MChief Financial OfficerMar 31, 2023 Option Exercise$3.908,29232,339292,323Apr 04, 2023, 05:04 PM
Templeman ThomasChief Technology OfficerMar 31, 2023 Option Exercise$3.904,10316,002188,244Apr 04, 2023, 05:04 PM
SAHA SAURABHChief Executive OfficerMar 31, 2023 Option Exercise$3.9022,01385,851895,362Apr 04, 2023, 05:03 PM
HUSSAIN IQBAL JGeneral CounselMar 31, 2023 Option Exercise$3.907,08027,612207,579Apr 04, 2023, 05:03 PM
GRAINGER DAVID JChief Innovation OfficerMar 31, 2023 Option Exercise$3.904,82518,818976,480Apr 04, 2023, 05:02 PM
Bush Tia LChief Quality OfficerMar 31, 2023 Option Exercise$3.904,31916,844157,102Apr 04, 2023, 05:01 PM
YVER ANTOINEEVP & Chairman of DevelopmentMar 01, 2023 Sale$3.427,00023,970806,681Mar 03, 2023, 05:04 PM
YVER ANTOINEEVP & Chairman of DevelopmentFeb 01, 2023 Sale$3.797,70029,201813,681Feb 03, 2023, 05:08 PM
Templeman ThomasChief Technology OfficerSep 30, 2022 Option Exercise$4.255,38222,874134,868Jan 13, 2023, 05:47 PM
GRAINGER DAVID JChief Innovation OfficerSep 30, 2022 Option Exercise$4.257,15430,405906,602Jan 13, 2023, 05:46 PM
CHAO DAVID MChief Administrative OfficerSep 30, 2022 Option Exercise$4.259,21139,147221,289Jan 13, 2023, 05:44 PM
HUSSAIN IQBAL JGeneral CounselSep 30, 2022 Option Exercise$4.2511,44548,641151,555Jan 13, 2023, 05:42 PM
Weinhoff Gregory MChief Financial OfficerSep 30, 2022 Option Exercise$4.2511,28247,949228,718Jan 13, 2023, 05:41 PM
YVER ANTOINEEVP & Chairman of DevelopmentSep 30, 2022 Option Exercise$4.257,73232,861782,019Jan 13, 2023, 05:40 PM
Bush Tia LChief Quality OfficerSep 30, 2022 Option Exercise$4.255,76524,501134,235Jan 13, 2023, 05:38 PM
YVER ANTOINEEVP & Chairman of DevelopmentDec 31, 2022 Option Exercise$3.102,2687,031758,883Jan 04, 2023, 07:30 PM
YVER ANTOINEEVP & Chairman of DevelopmentJan 04, 2023 Sale$3.186,97022,136751,913Jan 04, 2023, 07:30 PM
Weinhoff Gregory MChief Financial OfficerDec 31, 2022 Option Exercise$3.105,30316,439234,697Jan 04, 2023, 07:28 PM
Templeman ThomasChief Technology OfficerDec 31, 2022 Option Exercise$3.102,9219,055137,329Jan 04, 2023, 07:26 PM
SAHA SAURABHChief Executive OfficerDec 31, 2022 Option Exercise$3.1044,025136,477705,975Jan 04, 2023, 07:25 PM
HUSSAIN IQBAL JGeneral CounselDec 31, 2022 Option Exercise$3.103,99612,388159,004Jan 04, 2023, 07:23 PM
GRAINGER DAVID JChief Innovation OfficerDec 31, 2022 Option Exercise$3.102,4977,741911,259Jan 04, 2023, 07:20 PM
CHAO DAVID MChief Administrative OfficerDec 31, 2022 Option Exercise$3.104,88915,156225,611Jan 04, 2023, 07:18 PM
Bush Tia LChief Quality OfficerDec 31, 2022 Option Exercise$3.103,0149,343136,986Jan 04, 2023, 07:17 PM
YVER ANTOINEEVP & Chairman of DevelopmentDec 01, 2022 Sale$3.919,40036,744761,151Dec 05, 2022, 04:35 PM
YVER ANTOINEEVP & Chairman of DevelopmentOct 03, 2022 Sale$3.919,50037,108780,251Nov 23, 2022, 05:01 PM
YVER ANTOINEEVP & Chairman of DevelopmentNov 01, 2022 Sale$4.039,70039,055765,059Nov 03, 2022, 04:49 PM
CHAO DAVID MChief Administrative OfficerOct 03, 2022 Sale$3.954,16716,460222,932Oct 04, 2022, 05:07 PM
CHAO DAVID MChief Administrative OfficerSep 30, 2022 Sale$4.073,40113,833227,099Oct 04, 2022, 05:07 PM
Templeman ThomasChief Technology OfficerOct 03, 2022 Sale$3.952,4559,697135,792Oct 04, 2022, 05:06 PM
Templeman ThomasChief Technology OfficerSep 30, 2022 Sale$4.072,0038,147138,247Oct 04, 2022, 05:06 PM
GRAINGER DAVID JChief Innovation OfficerOct 03, 2022 Sale$3.952,85311,270908,575Oct 04, 2022, 05:04 PM
GRAINGER DAVID JChief Innovation OfficerSep 30, 2022 Sale$4.072,3289,469911,428Oct 04, 2022, 05:04 PM
Weinhoff Gregory MChief Financial OfficerOct 03, 2022 Sale$3.954,90119,359231,099Oct 04, 2022, 05:02 PM
Weinhoff Gregory MChief Financial OfficerSep 30, 2022 Sale$4.074,00016,270236,000Oct 04, 2022, 05:02 PM
YVER ANTOINEEVP & Chairman of DevelopmentOct 03, 2022 Sale$3.9212,52449,053774,759Oct 04, 2022, 04:59 PM
YVER ANTOINEEVP & Chairman of DevelopmentSep 30, 2022 Sale$4.072,46810,038787,283Oct 04, 2022, 04:59 PM
HUSSAIN IQBAL JGeneral CounselSep 30, 2022 Sale$4.073,72515,151159,275Oct 04, 2022, 04:57 PM
HUSSAIN IQBAL JGeneral CounselOct 03, 2022 Sale$3.954,56318,024154,712Oct 04, 2022, 04:57 PM
Shahidi JavadChief Medical OfficerOct 03, 2022 Sale$3.953,34113,197158,932Oct 04, 2022, 04:55 PM
Shahidi JavadChief Medical OfficerSep 30, 2022 Sale$4.072,72711,092162,273Oct 04, 2022, 04:55 PM
Bush Tia LChief Quality OfficerOct 03, 2022 Sale$3.952,59510,251135,287Oct 04, 2022, 04:52 PM
Bush Tia LChief Quality OfficerSep 30, 2022 Sale$4.072,1188,615137,882Oct 04, 2022, 04:52 PM
YVER ANTOINEEVP & Chairman of DevelopmentSep 01, 2022 Sale$4.4110,42345,987789,751Sep 02, 2022, 05:00 PM
YVER ANTOINEEVP & Chairman of DevelopmentAug 01, 2022 Sale$4.4510,42346,405800,174Aug 03, 2022, 06:00 PM
YVER ANTOINEEVP & Chairman of DevelopmentJul 18, 2022 Sale$4.8720,00097,312810,597Jul 20, 2022, 06:00 PM
YVER ANTOINEEVP & Chairman of DevelopmentJul 01, 2022 Sale$5.039,10045,797730,597Jul 06, 2022, 06:16 PM
SAHA SAURABHChief Executive OfficerJun 24, 2022 Buy$4.6310,00046,28438,000Jun 27, 2022, 09:28 PM
YVER ANTOINEEVP & Chairman of DevelopmentJun 17, 2022 Sale$4.689,20043,036739,697Jun 21, 2022, 07:23 PM
YVER ANTOINEEVP & Chairman of DevelopmentMay 18, 2022 Sale$5.1064,778330,102748,897May 19, 2022, 06:01 PM
YVER ANTOINEEVP & Chairman of DevelopmentMay 17, 2022 Sale$5.4220,222109,632813,675May 19, 2022, 06:01 PM
SAHA SAURABHChief Executive OfficerFeb 02, 2022 Buy$9.745,00048,70028,000Feb 04, 2022, 08:30 AM
GRAINGER DAVID JChief Innovation OfficerJan 28, 2022 Buy$9.0527,500248,75427,500Feb 01, 2022, 08:15 PM
De Rubertis FrancescoDirectorDec 02, 2021 Buy$12.8234,326440,0593,936,970Dec 06, 2021, 05:31 PM
Medicxi Ventures Management (Jersey) Ltd10% OwnerDec 02, 2021 Buy$12.8234,326440,0593,936,970Dec 06, 2021, 05:11 PM
De Rubertis FrancescoDirectorDec 01, 2021 Buy$12.6260,304761,0363,903,440Dec 02, 2021, 05:24 PM
De Rubertis FrancescoDirectorNov 30, 2021 Buy$11.6236,847428,1623,844,535Dec 02, 2021, 05:24 PM
Medicxi Ventures Management (Jersey) Ltd10% OwnerDec 01, 2021 Buy$12.6260,304761,0363,903,440Dec 02, 2021, 05:10 PM
Medicxi Ventures Management (Jersey) Ltd10% OwnerNov 30, 2021 Buy$11.6236,847428,1623,844,535Dec 02, 2021, 05:10 PM
De Rubertis FrancescoDirectorNov 29, 2021 Buy$11.7056,706663,4773,808,543Nov 30, 2021, 05:26 PM
De Rubertis FrancescoDirectorNov 26, 2021 Buy$11.3411,817133,9493,753,152Nov 30, 2021, 05:26 PM
Medicxi Ventures Management (Jersey) Ltd10% OwnerNov 29, 2021 Buy$11.7056,706663,4773,808,543Nov 30, 2021, 05:11 PM
Medicxi Ventures Management (Jersey) Ltd10% OwnerNov 26, 2021 Buy$11.3411,817133,9493,753,152Nov 30, 2021, 05:11 PM
KANTOFF AARONDirectorNov 18, 2021 Buy$11.9810,000119,85060,000Nov 18, 2021, 08:30 PM
SAHA SAURABHChief Executive OfficerNov 16, 2021 Buy$12.2823,000282,47223,000Nov 18, 2021, 07:00 PM
Bush Tia LChief Quality OfficerNov 16, 2021 Buy$12.465,00062,3028,000Nov 18, 2021, 07:00 PM
De Rubertis FrancescoDirectorJun 02, 2021 Buy$20.00600,00012,000,0003,741,609Jun 04, 2021, 05:01 PM
CHAO DAVID MChief Administrative OfficerJun 02, 2021 Buy$20.0050010,000500Jun 04, 2021, 05:00 PM
HUSSAIN IQBAL JGeneral CounselJun 02, 2021 Buy$20.003,00060,0003,000Jun 04, 2021, 05:00 PM
HUSSAIN IQBAL JGeneral CounselJun 02, 2021 Buy$20.005,500110,0005,500Jun 04, 2021, 05:00 PM
GOYAL ARJUNDirectorJun 02, 2021 Buy$20.00750,00015,000,0003,825,659Jun 04, 2021, 05:00 PM
Thorell MarellaChief Accounting OfficerJun 02, 2021 Buy$20.001,00020,0001,000Jun 04, 2021, 05:00 PM
Weinhoff Gregory MChief Financial OfficerJun 02, 2021 Buy$20.0010,000200,00010,000Jun 04, 2021, 05:00 PM
Medicxi Ventures Management (Jersey) Ltd10% OwnerJun 02, 2021 Buy$20.00600,00012,000,0003,741,609Jun 04, 2021, 04:30 PM
GAP (Bermuda) LTD10% OwnerJun 02, 2021 Buy$20.001,500,00030,000,0009,681,818Jun 03, 2021, 12:24 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Anderson Karen M.Chief People Officer03/25/2024177,252
Anderson Karen M.Chief People Officer03/25/2024607,960
CHAO DAVID MChief Administrative Officer02/01/202477,830
HUSSAIN IQBAL JGeneral Counsel02/01/202464,578
Weinhoff Gregory MChief Financial Officer02/01/202494,136
SAHA SAURABHChief Executive Officer02/01/2024215,585
Bush Tia LChief Quality Officer02/01/202431,630
Rotman HarrisSVP Regulatory Affairs02/01/202433,645
Rotman HarrisSVP Regulatory Affairs02/01/202434,574
Anderson Karen M.Chief People Officer02/01/202459,500
CHAO DAVID MChief Administrative Officer12/31/202382,935
Weinhoff Gregory MChief Financial Officer12/31/202393,466
HUSSAIN IQBAL JGeneral Counsel12/31/202359,859
SAHA SAURABHChief Executive Officer12/31/2023288,653
GRAINGER DAVID JChief Innovation Officer12/31/202337,412
Bush Tia LChief Quality Officer12/31/202351,095
HUSSAIN IQBAL JGeneral Counsel09/30/202348,654
GRAINGER DAVID JChief Innovation Officer09/30/202330,409
Weinhoff Gregory MChief Financial Officer09/30/202375,971
SAHA SAURABHChief Executive Officer09/30/2023234,622
CHAO DAVID MChief Administrative Officer09/30/202367,411
Bush Tia LChief Quality Officer09/30/202341,531
Rotman HarrisSVP Regulatory Affairs09/20/2023163,688
Rotman HarrisSVP Regulatory Affairs09/20/2023235,688
CHAO DAVID MChief Administrative Officer06/30/202361,473
HUSSAIN IQBAL JGeneral Counsel06/30/202341,914
Weinhoff Gregory MChief Financial Officer06/30/202369,279
SAHA SAURABHChief Executive Officer06/30/2023213,955
GRAINGER DAVID JChief Innovation Officer06/30/202325,311
Bush Tia LChief Quality Officer06/30/202337,873
YVER ANTOINEEVP & Chairman of Development06/01/202328,949
Bush Tia LChief Quality Officer05/24/202335,865
YVER ANTOINEEVP & Chairman of Development05/01/202330,083
Weinhoff Gregory MChief Financial Officer03/31/202332,339
Templeman ThomasChief Technology Officer03/31/202316,002
SAHA SAURABHChief Executive Officer03/31/202385,851
HUSSAIN IQBAL JGeneral Counsel03/31/202327,612
GRAINGER DAVID JChief Innovation Officer03/31/202318,818
Bush Tia LChief Quality Officer03/31/202316,844
YVER ANTOINEEVP & Chairman of Development03/01/202323,970
YVER ANTOINEEVP & Chairman of Development02/01/202329,201
Templeman ThomasChief Technology Officer09/30/202222,874
GRAINGER DAVID JChief Innovation Officer09/30/202230,405
CHAO DAVID MChief Administrative Officer09/30/202239,147
HUSSAIN IQBAL JGeneral Counsel09/30/202248,641
Weinhoff Gregory MChief Financial Officer09/30/202247,949
YVER ANTOINEEVP & Chairman of Development09/30/202232,861
Bush Tia LChief Quality Officer09/30/202224,501
YVER ANTOINEEVP & Chairman of Development12/31/20227,031
YVER ANTOINEEVP & Chairman of Development01/04/202322,136
Weinhoff Gregory MChief Financial Officer12/31/202216,439
Templeman ThomasChief Technology Officer12/31/20229,055
SAHA SAURABHChief Executive Officer12/31/2022136,477
HUSSAIN IQBAL JGeneral Counsel12/31/202212,388
GRAINGER DAVID JChief Innovation Officer12/31/20227,741
CHAO DAVID MChief Administrative Officer12/31/202215,156
Bush Tia LChief Quality Officer12/31/20229,343
YVER ANTOINEEVP & Chairman of Development12/01/202236,744
YVER ANTOINEEVP & Chairman of Development10/03/202237,108
YVER ANTOINEEVP & Chairman of Development11/01/202239,055
CHAO DAVID MChief Administrative Officer10/03/202216,460
CHAO DAVID MChief Administrative Officer09/30/202213,833
Templeman ThomasChief Technology Officer10/03/20229,697
Templeman ThomasChief Technology Officer09/30/20228,147
GRAINGER DAVID JChief Innovation Officer10/03/202211,270
GRAINGER DAVID JChief Innovation Officer09/30/20229,469
Weinhoff Gregory MChief Financial Officer10/03/202219,359
Weinhoff Gregory MChief Financial Officer09/30/202216,270
YVER ANTOINEEVP & Chairman of Development10/03/202249,053
YVER ANTOINEEVP & Chairman of Development09/30/202210,038
HUSSAIN IQBAL JGeneral Counsel09/30/202215,151
HUSSAIN IQBAL JGeneral Counsel10/03/202218,024
Shahidi JavadChief Medical Officer10/03/202213,197
Shahidi JavadChief Medical Officer09/30/202211,092
Bush Tia LChief Quality Officer10/03/202210,251
Bush Tia LChief Quality Officer09/30/20228,615
YVER ANTOINEEVP & Chairman of Development09/01/202245,987
YVER ANTOINEEVP & Chairman of Development08/01/202246,405
YVER ANTOINEEVP & Chairman of Development07/18/202297,312
YVER ANTOINEEVP & Chairman of Development07/01/202245,797
SAHA SAURABHChief Executive Officer06/24/202246,284
YVER ANTOINEEVP & Chairman of Development06/17/202243,036
YVER ANTOINEEVP & Chairman of Development05/18/2022330,102
YVER ANTOINEEVP & Chairman of Development05/17/2022109,632
SAHA SAURABHChief Executive Officer02/02/202248,700
GRAINGER DAVID JChief Innovation Officer01/28/2022248,754
De Rubertis FrancescoDirector12/02/2021440,059
Medicxi Ventures Management (Jersey) Ltd10% Owner12/02/2021440,059
De Rubertis FrancescoDirector12/01/2021761,036
De Rubertis FrancescoDirector11/30/2021428,162
Medicxi Ventures Management (Jersey) Ltd10% Owner12/01/2021761,036
Medicxi Ventures Management (Jersey) Ltd10% Owner11/30/2021428,162
De Rubertis FrancescoDirector11/29/2021663,477
De Rubertis FrancescoDirector11/26/2021133,949
Medicxi Ventures Management (Jersey) Ltd10% Owner11/29/2021663,477
Medicxi Ventures Management (Jersey) Ltd10% Owner11/26/2021133,949
KANTOFF AARONDirector11/18/2021119,850
SAHA SAURABHChief Executive Officer11/16/2021282,472
Bush Tia LChief Quality Officer11/16/202162,302
De Rubertis FrancescoDirector06/02/202112,000,000
CHAO DAVID MChief Administrative Officer06/02/202110,000
HUSSAIN IQBAL JGeneral Counsel06/02/202160,000
HUSSAIN IQBAL JGeneral Counsel06/02/2021110,000
GOYAL ARJUNDirector06/02/202115,000,000
Thorell MarellaChief Accounting Officer06/02/202120,000
Weinhoff Gregory MChief Financial Officer06/02/2021200,000
Medicxi Ventures Management (Jersey) Ltd10% Owner06/02/202112,000,000
GAP (Bermuda) LTD10% Owner06/02/202130,000,000
Load More Insider Transactions
FUNDS WITH A POSITION IN CENTESSA PHARMACEUTICALS PLC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ADAGE CAPITAL PARTNERS GP, L.L.C.2,896,1280.05%2.32%Other
PLATINUM INVESTMENT MANAGEMENT LTD381,0830.12%12.9%Growth At A Reasonable Price, Value
BLACKROCK INC.346,2710.00007%6.27%Other
DRIEHAUS CAPITAL MANAGEMENT LLC289,3810.03%NewGrowth
RENAISSANCE TECHNOLOGIES LLC185,6000.00229%249.53%Other
GEODE CAPITAL MANAGEMENT, LLC33,5390.00003%5.36%Other
CHANGE IN SHARES OUTSTANDING FOR CENTESSA PHARMACEUTICALS PLC
STOCK BUYBACKS FOR CENTESSA PHARMACEUTICALS PLC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
1.56%
1Q
09/30/2023
03/31/2023
1.80%
2Q
09/30/2023
12/31/2022
2.15%
3Q
09/30/2023
09/30/2022
2.46%
4Q
09/30/2023
06/30/2022
2.70%
5Q
09/30/2023
03/31/2022
6.79%
6Q
09/30/2023
12/31/2021
28.58%
7Q
09/30/2023
09/30/2021
7.51%
8Q
09/30/2023
06/30/2021
52.16%
9Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
1.56%
1Q
03/31/2023
1.80%
2Q
12/31/2022
2.15%
3Q
09/30/2022
2.46%
4Q
06/30/2022
2.70%
5Q
03/31/2022
6.79%
6Q
12/31/2021
28.58%
7Q
09/30/2021
7.51%
8Q
06/30/2021
52.16%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CENTESSA PHARMACEUTICALS PLC
LOADING...